{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:32:12Z","timestamp":1791545532870,"version":"4.3.4"},"reference-count":218,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T00:00:00Z","timestamp":1398729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T00:00:00Z","timestamp":1398729600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1038\/nrcardio.2014.59","type":"journal-article","created":{"date-parts":[[2014,4,29]],"date-time":"2014-04-29T07:11:41Z","timestamp":1398755501000},"page":"413-426","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":388,"title":["Angiotensin-converting enzyme 2 and angiotensin 1\u20137: novel therapeutic targets"],"prefix":"10.1038","volume":"11","author":[{"given":"Fan","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongtao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunye","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang Fang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,29]]},"reference":[{"key":"BFnrcardio201459_CR1","doi-asserted-by":"publisher","first-page":"H1219","DOI":"10.1152\/ajpheart.00796.2011","volume":"302","author":"K Putnam","year":"2012","unstructured":"Putnam, K., Shoemaker, R., Yiannikouris, F. & Cassis, L. A. The renin-angiotensin system: a target of and contributor to dyslipidemias, altered glucose homeostasis, and hypertension of the metabolic syndrome. Am. J. Physiol. Heart Circ. Physiol. 302, H1219\u2013H1230 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/nrcardio.2012.196","volume":"10","author":"CC Lang","year":"2013","unstructured":"Lang, C. C. & Struthers, A. D. Targeting the renin-angiotensin-aldosterone system in heart failure. Nat. Rev. Cardiol. 10, 125\u2013134 (2013).","journal-title":"Nat. Rev. Cardiol."},{"key":"BFnrcardio201459_CR3","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/j.peptides.2011.09.010","volume":"32","author":"A Nguyen Dinh Cat","year":"2011","unstructured":"Nguyen Dinh Cat, A. & Touyz, R. M. A new look at the renin-angiotensin system\u2014focusing on the vascular system. Peptides 32, 2141\u20132150 (2011).","journal-title":"Peptides"},{"key":"BFnrcardio201459_CR4","doi-asserted-by":"publisher","first-page":"30A","DOI":"10.1016\/j.amjcard.2009.10.009","volume":"105","author":"BJ Hoogwerf","year":"2010","unstructured":"Hoogwerf, B. J. Renin-angiotensin system blockade and cardiovascular and renal protection. Am. J. Cardiol. 105, 30A\u201335A (2010).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201459_CR5","doi-asserted-by":"publisher","first-page":"39","DOI":"10.4149\/endo_2013_01_39","volume":"47","author":"I Herichova","year":"2013","unstructured":"Herichova, I. & Szantoova, K. Renin-angiotensin system: upgrade of recent knowledge and perspectives. Endocr. Regul. 47, 39\u201352 (2013).","journal-title":"Endocr. Regul."},{"key":"BFnrcardio201459_CR6","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1016\/j.peptides.2011.06.018","volume":"32","author":"WC De Mello","year":"2011","unstructured":"De Mello, W. C. & Frohlich, E. D. On the local cardiac renin angiotensin system. Basic and clinical implications. Peptides 32, 1774\u20131779 (2011).","journal-title":"Peptides"},{"key":"BFnrcardio201459_CR7","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00424-012-1120-0","volume":"465","author":"M Bader","year":"2013","unstructured":"Bader, M. ACE2, angiotensin-(1\u20137), and Mas: the other side of the coin. Pflugers Arch. 465, 79\u201385 (2013).","journal-title":"Pflugers Arch."},{"key":"BFnrcardio201459_CR8","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","volume":"87","author":"M Donoghue","year":"2000","unstructured":"Donoghue, M. et al. A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1\u20139. Circ. Res. 87, E1\u2013E9 (2000).","journal-title":"Circ. Res."},{"key":"BFnrcardio201459_CR9","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","volume":"275","author":"SR Tipnis","year":"2000","unstructured":"Tipnis, S. R. et al. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J. Biol. Chem. 275, 33238\u201333243 (2000).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio201459_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.acvd.2012.02.010","volume":"105","author":"C Guang","year":"2012","unstructured":"Guang, C., Phillips, R. D., Jiang, B. & Milani, F. Three key proteases\u2014angiotensin-I-converting enzyme (ACE), ACE2 and renin\u2014within and beyond the renin-angiotensin system. Arch. Cardiovasc. Dis. 105, 373\u2013385 (2012).","journal-title":"Arch. Cardiovasc. Dis."},{"key":"BFnrcardio201459_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1253\/circj.CJ-12-1544","volume":"77","author":"K Kuba","year":"2013","unstructured":"Kuba, K., Imai, Y. & Penninger, J. M. Multiple functions of angiotensin-converting enzyme 2 and its relevance in cardiovascular diseases. Circ. J. 77, 301\u2013308 (2013).","journal-title":"Circ. J."},{"key":"BFnrcardio201459_CR12","doi-asserted-by":"publisher","first-page":"307315","DOI":"10.1155\/2012\/307315","volume":"2012","author":"NE Clarke","year":"2012","unstructured":"Clarke, N. E. & Turner, A. J. Angiotensin-converting enzyme 2: the first decade. Int. J. Hypertens. 2012, 307315 (2012).","journal-title":"Int. J. Hypertens."},{"key":"BFnrcardio201459_CR13","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1111\/j.1742-4658.2005.04756.x","volume":"272","author":"JL Guy","year":"2005","unstructured":"Guy, J. L., Jackson, R. M., Jensen, H. A., Hooper, N. M. & Turner, A. J. Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. FEBS J. 272, 3512\u20133520 (2005).","journal-title":"FEBS J."},{"key":"BFnrcardio201459_CR14","doi-asserted-by":"publisher","first-page":"17132","DOI":"10.1074\/jbc.M006723200","volume":"276","author":"H Zhang","year":"2001","unstructured":"Zhang, H. et al. Collectrin, a collecting duct-specific transmembrane glycoprotein, is a novel homolog of ACE2 and is developmentally regulated in embryonic kidneys. J. Biol. Chem. 276, 17132\u201317139 (2001).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio201459_CR15","doi-asserted-by":"publisher","first-page":"13185","DOI":"10.1021\/bi035268s","volume":"42","author":"JL Guy","year":"2003","unstructured":"Guy, J. L. et al. Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry 42, 13185\u201313192 (2003).","journal-title":"Biochemistry"},{"key":"BFnrcardio201459_CR16","doi-asserted-by":"publisher","first-page":"14838","DOI":"10.1074\/jbc.M200581200","volume":"277","author":"C Vickers","year":"2002","unstructured":"Vickers, C. et al. Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J. Biol. Chem. 277, 14838\u201314843 (2002).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio201459_CR17","doi-asserted-by":"publisher","first-page":"H2281","DOI":"10.1152\/ajpheart.00618.2005","volume":"289","author":"CM Ferrario","year":"2005","unstructured":"Ferrario, C. M., Trask, A. J. & Jessup, J. A. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1\u20137) in regulation of cardiovascular function. Am. J. Physiol. Heart Circ. Physiol. 289, H2281\u2013H2290 (2005).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR18","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/JOE-12-0341","volume":"216","author":"RA Santos","year":"2013","unstructured":"Santos, R. A., Ferreira, A. J., Verano-Braga, T. & Bader, M. Angiotensin-converting enzyme 2, angiotensin-(1\u20137) and Mas: new players of the renin-angiotensin system. J. Endocrinol. 216, R1\u2013R17 (2013).","journal-title":"J. Endocrinol."},{"key":"BFnrcardio201459_CR19","doi-asserted-by":"publisher","first-page":"e45564","DOI":"10.1371\/journal.pone.0045564","volume":"7","author":"M Flores-Munoz","year":"2012","unstructured":"Flores-Munoz, M., Godinho, B. M., Almalik, A. & Nicklin, S. A. Adenoviral delivery of angiotensin-(1\u20137) or angiotensin-(1\u20139) inhibits cardiomyocyte hypertrophy via the mas or angiotensin type 2 receptor. PLoS ONE 7, e45564 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrcardio201459_CR20","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1161\/HYPERTENSIONAHA.111.177485","volume":"59","author":"M Flores-Munoz","year":"2012","unstructured":"Flores-Munoz, M. et al. Angiotensin-(1\u20139) attenuates cardiac fibrosis in the stroke-prone spontaneously hypertensive rat via the angiotensin type 2 receptor. Hypertension 59, 300\u2013307 (2012).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR21","doi-asserted-by":"publisher","first-page":"30113","DOI":"10.1074\/jbc.M505111200","volume":"280","author":"DW Lambert","year":"2005","unstructured":"Lambert, D. W. et al. Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). J. Biol. Chem. 280, 30113\u201330119 (2005).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio201459_CR22","doi-asserted-by":"publisher","first-page":"C1318","DOI":"10.1152\/ajpcell.00036.2009","volume":"297","author":"M Iwata","year":"2009","unstructured":"Iwata, M., Silva Enciso, J. E. & Greenberg, B. H. Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor \u03b1-converting enzyme. Am. J. Physiol. Cell Physiol. 297, C1318\u2013C1329 (2009).","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"BFnrcardio201459_CR23","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.jacc.2008.02.088","volume":"52","author":"S Epelman","year":"2008","unstructured":"Epelman, S. et al. Detection of soluble angiotensin-converting enzyme 2 in heart failure: insights into the endogenous counter-regulatory pathway of the renin-angiotensin-aldosterone system. J. Am. Coll. Cardiol. 52, 750\u2013754 (2008).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201459_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cardfail.2009.01.014","volume":"15","author":"S Epelman","year":"2009","unstructured":"Epelman, S. et al. Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. J. Card Fail 15, 565\u2013571 (2009).","journal-title":"J. Card Fail"},{"key":"BFnrcardio201459_CR25","doi-asserted-by":"publisher","first-page":"e61695","DOI":"10.1371\/journal.pone.0061695","volume":"8","author":"JT Ortiz-Perez","year":"2013","unstructured":"Ortiz-Perez, J. T. et al. Role of circulating angiotensin converting enzyme 2 in left ventricular remodeling following myocardial infarction: a prospective controlled study. PLoS ONE 8, e61695 (2013).","journal-title":"PLoS ONE"},{"key":"BFnrcardio201459_CR26","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","volume":"66","author":"VB Patel","year":"2014","unstructured":"Patel, V. B. et al. Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS. J. Mol. Cell Cardiol. 66, 167\u2013176 (2014).","journal-title":"J. Mol. Cell Cardiol."},{"key":"BFnrcardio201459_CR27","doi-asserted-by":"publisher","first-page":"11852","DOI":"10.1021\/ja0277226","volume":"124","author":"NA Dales","year":"2002","unstructured":"Dales, N. A. et al. Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J. Am. Chem. Soc. 124, 11852\u201311853 (2002).","journal-title":"J. Am. Chem. Soc."},{"key":"BFnrcardio201459_CR28","doi-asserted-by":"publisher","first-page":"17996","DOI":"10.1074\/jbc.M311191200","volume":"279","author":"P Towler","year":"2004","unstructured":"Towler, P. et al. ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. J. Biol. Chem. 279, 17996\u201318007 (2004).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio201459_CR29","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1038\/sj.ki.5002373","volume":"72","author":"MJ Soler","year":"2007","unstructured":"Soler, M. J. et al. ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney Int. 72, 614\u2013623 (2007).","journal-title":"Kidney Int."},{"key":"BFnrcardio201459_CR30","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/ajh.2010.51","volume":"23","author":"AJ Trask","year":"2010","unstructured":"Trask, A. J. et al. Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats. Am. J. Hypertens. 23, 687\u2013693 (2010).","journal-title":"Am. J. Hypertens."},{"key":"BFnrcardio201459_CR31","doi-asserted-by":"publisher","first-page":"15532","DOI":"10.1074\/jbc.M212934200","volume":"278","author":"L Huang","year":"2003","unstructured":"Huang, L. et al. Novel peptide inhibitors of angiotensin-converting enzyme 2. J. Biol. Chem. 278, 15532\u201315540 (2003).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio201459_CR32","doi-asserted-by":"publisher","first-page":"L269","DOI":"10.1152\/ajplung.00222.2010","volume":"301","author":"BD Uhal","year":"2011","unstructured":"Uhal, B. D., Li, X., Xue, A., Gao, X. & Abdul-Hafez, A. Regulation of alveolar epithelial cell survival by the ACE-2\/angiotensin 1\u20137\/Mas axis. Am. J. Physiol. Lung Cell. Mol. Physiol. 301, L269\u2013L274 (2011).","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"BFnrcardio201459_CR33","doi-asserted-by":"publisher","first-page":"210","DOI":"10.2119\/molmed.2009.00160","volume":"16","author":"RA Fraga-Silva","year":"2010","unstructured":"Fraga-Silva, R. A. et al. ACE2 activation promotes antithrombotic activity. Mol. Med. 16, 210\u2013215 (2010).","journal-title":"Mol. Med."},{"key":"BFnrcardio201459_CR34","doi-asserted-by":"publisher","first-page":"R1293","DOI":"10.1152\/ajpregu.00339.2011","volume":"301","author":"KB Pedersen","year":"2011","unstructured":"Pedersen, K. B., Sriramula, S., Chhabra, K. H., Xia, H. & Lazartigues, E. Species-specific inhibitor sensitivity of angiotensin-converting enzyme 2 (ACE2) and its implication for ACE2 activity assays. Am. J. Physiol. Regul. Integr. Comp. Physiol. 301, R1293\u2013R1299 (2011).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrcardio201459_CR35","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1161\/HYPERTENSIONAHA.112.198622","volume":"60","author":"M Ye","year":"2012","unstructured":"Ye, M. et al. Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2. Hypertension 60, 730\u2013740 (2012).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR36","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1161\/HYPERTENSIONAHA.107.108944","volume":"51","author":"JA Hern\u00e1ndez Prada","year":"2008","unstructured":"Hern\u00e1ndez Prada, J. A. et al. Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents. Hypertension 51, 1312\u20131317 (2008).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1113\/expphysiol.2010.055277","volume":"96","author":"AJ Ferreira","year":"2011","unstructured":"Ferreira, A. J. et al. Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases. Exp. Physiol. 96, 287\u2013294 (2011).","journal-title":"Exp. Physiol."},{"key":"BFnrcardio201459_CR38","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/HYPERTENSIONAHA.113.02856","volume":"63","author":"PK Haber","year":"2014","unstructured":"Haber, P. K. et al. Angiotensin-converting enzyme 2-independent action of presumed angiotensin-converting enzyme 2 activators: studies in vivo, ex vivo, and in vitro. Hypertension 63, 774\u2013782 (2014).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR39","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1097\/00004872-200410000-00020","volume":"22","author":"DJ Campbell","year":"2004","unstructured":"Campbell, D. J., Zeitz, C. J., Esler, M. D. & Horowitz, J. D. Evidence against a major role for angiotensin converting enzyme-related carboxypeptidase (ACE2) in angiotensin peptide metabolism in the human coronary circulation. J. Hypertens. 22, 1971\u20131976 (2004).","journal-title":"J. Hypertens."},{"key":"BFnrcardio201459_CR40","doi-asserted-by":"publisher","first-page":"7398","DOI":"10.1158\/1078-0432.CCR-09-1957","volume":"15","author":"WJ Petty","year":"2009","unstructured":"Petty, W. J. et al. Phase I and pharmacokinetic study of angiotensin-(1\u20137), an endogenous antiangiogenic hormone. Clin. Cancer Res. 15, 7398\u20137404 (2009).","journal-title":"Clin. Cancer Res."},{"key":"BFnrcardio201459_CR41","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/01.HYP.32.3.496","volume":"32","author":"K Yamada","year":"1998","unstructured":"Yamada, K., Iyer, S. N., Chappell, M. C., Ganten, D. & Ferrario, C. M. Converting enzyme determines plasma clearance of angiotensin-(1\u20137). Hypertension 32, 496\u2013502 (1998).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR42","doi-asserted-by":"publisher","first-page":"F841","DOI":"10.1152\/ajprenal.2000.279.5.F841","volume":"279","author":"AJ Allred","year":"2000","unstructured":"Allred, A. J., Diz, D. I., Ferrario, C. M. & Chappell, M. C. Pathways for angiotensin-(1\u20137) metabolism in pulmonary and renal tissues. Am. J. Physiol. Renal Physiol. 279, F841\u2013F850 (2000).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrcardio201459_CR43","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.ejphar.2008.02.090","volume":"585","author":"D Iusuf","year":"2008","unstructured":"Iusuf, D., Henning, R. H., van Gilst, W. H. & Roks, A. J. Angiotensin-(1\u20137): pharmacological properties and pharmacotherapeutic perspectives. Eur. J. Pharmacol. 585, 303\u2013312 (2008).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnrcardio201459_CR44","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1042\/CS20120111","volume":"123","author":"D Zimmerman","year":"2012","unstructured":"Zimmerman, D. & Burns, K. D. Angiotensin-(1\u20137) in kidney disease: a review of the controversies. Clin. Sci. (Lond.) 123, 333\u2013346 (2012).","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnrcardio201459_CR45","doi-asserted-by":"publisher","first-page":"E262","DOI":"10.1152\/ajpendo.90678.2008","volume":"296","author":"JF Giani","year":"2009","unstructured":"Giani, J. F. et al. Chronic infusion of angiotensin-(1\u20137) improves insulin resistance and hypertension induced by a high-fructose diet in rats. Am. J. Physiol. Endocrinol. Metab. 296, E262\u2013E271 (2009).","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"BFnrcardio201459_CR46","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.peptides.2013.10.022","volume":"51","author":"O Echeverria-Rodriguez","year":"2014","unstructured":"Echeverria-Rodriguez, O., Del Valle-Mondragon, L. & Hong, E. Angiotensin 1\u20137 improves insulin sensitivity by increasing skeletal muscle glucose uptake in vivo. Peptides 51, 26\u201330 (2014).","journal-title":"Peptides"},{"key":"BFnrcardio201459_CR47","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1161\/ATVBAHA.109.200493","volume":"30","author":"SH Santos","year":"2010","unstructured":"Santos, S. H. et al. Improved lipid and glucose metabolism in transgenic rats with increased circulating angiotensin-(1\u20137). Arterioscler. Thromb. Vasc. Biol. 30, 953\u2013961 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201459_CR48","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/S0022-2828(03)00177-9","volume":"35","author":"M Donoghue","year":"2003","unstructured":"Donoghue, M. et al. Heart block, ventricular tachycardia, and sudden death in ACE2 transgenic mice with downregulated connexins. J. Mol. Cell Cardiol. 35, 1043\u20131053 (2003).","journal-title":"J. Mol. Cell Cardiol."},{"key":"BFnrcardio201459_CR49","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1590\/S0100-879X1997000600016","volume":"30","author":"LA Neves","year":"1997","unstructured":"Neves, L. A., Almeida, A. P., Khosla, M. C., Campagnole-Santos, M. J. & Santos, R. A. Effect of angiotensin-(1\u20137) on reperfusion arrhythmias in isolated rat hearts. Braz. J. Med. Biol. Res. 30, 801\u2013809 (1997).","journal-title":"Braz. J. Med. Biol. Res."},{"key":"BFnrcardio201459_CR50","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3317\/jraas.2007.015","volume":"8","author":"WC De Mello","year":"2007","unstructured":"De Mello, W. C., Ferrario, C. M. & Jessup, J. A. Beneficial versus harmful effects of angiotensin (1\u20137) on impulse propagation and cardiac arrhythmias in the failing heart. J. Renin Angiotensin Aldosterone Syst. 8, 74\u201380 (2007).","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"BFnrcardio201459_CR51","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/HYPERTENSIONAHA.108.114280","volume":"52","author":"MF Dias-Peixoto","year":"2008","unstructured":"Dias-Peixoto, M. F. et al. Molecular mechanisms involved in the angiotensin-(1\u20137)\/Mas signaling pathway in cardiomyocytes. Hypertension 52, 542\u2013548 (2008).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR52","doi-asserted-by":"publisher","first-page":"H1154","DOI":"10.1152\/ajpheart.01395.2006","volume":"293","author":"JF Giani","year":"2007","unstructured":"Giani, J. F. et al. Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. Am. J. Physiol. Heart Circ. Physiol. 293, H1154\u2013H1163 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR53","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1161\/01.HYP.0000251865.35728.2f","volume":"49","author":"WO Sampaio","year":"2007","unstructured":"Sampaio, W. O. et al. Angiotensin-(1\u20137) through receptor Mas mediates endothelial nitric oxide synthase activation via Akt-dependent pathways. Hypertension 49, 185\u2013192 (2007).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR54","doi-asserted-by":"publisher","first-page":"15520","DOI":"10.1074\/jbc.M113.459792","volume":"288","author":"A Than","year":"2013","unstructured":"Than, A., Leow, M. K. & Chen, P. Control of adipogenesis by the autocrine interplays between angiotensin 1\u20137\/Mas receptor and angiotensin II\/AT1 receptor signaling pathways. J. Biol. Chem. 288, 15520\u201315531 (2013).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio201459_CR55","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.regpep.2010.02.001","volume":"161","author":"MC Munoz","year":"2010","unstructured":"Munoz, M. C., Giani, J. F. & Dominici, F. P. Angiotensin-(1\u20137) stimulates the phosphorylation of Akt in rat extracardiac tissues in vivo via receptor Mas. Regul. Pept. 161, 1\u20137 (2010).","journal-title":"Regul. Pept."},{"key":"BFnrcardio201459_CR56","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1161\/HYPERTENSIONAHA.106.084848","volume":"50","author":"WO Sampaio","year":"2007","unstructured":"Sampaio, W. O., Henrique de Castro, C., Santos, R. A., Schiffrin, E. L. & Touyz, R. M. Angiotensin-(1\u20137) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 50, 1093\u20131098 (2007).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR57","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/01.HYP.0000090322.55782.30","volume":"42","author":"EA Tallant","year":"2003","unstructured":"Tallant, E. A. & Clark, M. A. Molecular mechanisms of inhibition of vascular growth by angiotensin-(1\u20137). Hypertension 42, 574\u2013579 (2003).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR58","doi-asserted-by":"publisher","first-page":"e12323","DOI":"10.1371\/journal.pone.0012323","volume":"5","author":"F Zhang","year":"2010","unstructured":"Zhang, F., Hu, Y., Xu, Q. & Ye, S. Different effects of angiotensin II and angiotensin-(1\u20137) on vascular smooth muscle cell proliferation and migration. PLoS ONE 5, e12323 (2010).","journal-title":"PLoS ONE"},{"key":"BFnrcardio201459_CR59","doi-asserted-by":"publisher","first-page":"H1560","DOI":"10.1152\/ajpheart.00941.2004","volume":"289","author":"EA Tallant","year":"2005","unstructured":"Tallant, E. A., Ferrario, C. M. & Gallagher, P. E. Angiotensin-(1\u20137) inhibits growth of cardiac myocytes through activation of the mas receptor. Am. J. Physiol. Heart Circ. Physiol. 289, H1560\u2013H1566 (2005).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR60","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1038\/sj.ki.5001509","volume":"69","author":"Z Su","year":"2006","unstructured":"Su, Z., Zimpelmann, J. & Burns, K. D. Angiotensin-(1\u20137) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells. Kidney Int. 69, 2212\u20132218 (2006).","journal-title":"Kidney Int."},{"key":"BFnrcardio201459_CR61","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.molimm.2008.10.022","volume":"46","author":"W Nie","year":"2009","unstructured":"Nie, W. et al. Angiotensin-(1\u20137) enhances angiotensin II induced phosphorylation of ERK1\/2 in mouse bone marrow-derived dendritic cells. Mol. Immunol. 46, 355\u2013361 (2009).","journal-title":"Mol. Immunol."},{"key":"BFnrcardio201459_CR62","doi-asserted-by":"publisher","first-page":"F337","DOI":"10.1152\/ajprenal.90437.2008","volume":"296","author":"J Zimpelmann","year":"2009","unstructured":"Zimpelmann, J. & Burns, K. D. Angiotensin-(1\u20137) activates growth-stimulatory pathways in human mesangial cells. Am. J. Physiol. Renal Physiol. 296, F337\u2013F346 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrcardio201459_CR63","doi-asserted-by":"publisher","first-page":"F784","DOI":"10.1152\/ajprenal.00455.2011","volume":"302","author":"GC Liu","year":"2012","unstructured":"Liu, G. C., Oudit, G. Y., Fang, F., Zhou, J. & Scholey, J. W. Angiotensin-(1\u20137)-induced activation of ERK1\/2 is cAMP\/protein kinase A-dependent in glomerular mesangial cells. Am. J. Physiol. Renal Physiol. 302, F784\u2013F790 (2012).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrcardio201459_CR64","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jash.2013.08.003","volume":"8","author":"WC De Mello","year":"2014","unstructured":"De Mello, W. C. Angiotensin (1\u20137) increases the potassium current and the resting potential of arterial myocytes from vascular resistance vessels of normal adult rats: pathophysiological implications. J. Am. Soc. Hypertens. 8, 14\u201320 (2014).","journal-title":"J. Am. Soc. Hypertens."},{"key":"BFnrcardio201459_CR65","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/0167-0115(95)00010-9","volume":"56","author":"BP Rowe","year":"1995","unstructured":"Rowe, B. P., Saylor, D. L., Speth, R. C. & Absher, D. R. Angiotensin-(1\u20137) binding at angiotensin II receptors in the rat brain. Regul. Pept. 56, 139\u2013146 (1995).","journal-title":"Regul. Pept."},{"key":"BFnrcardio201459_CR66","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0167-0115(99)00067-1","volume":"84","author":"MM Gironacci","year":"1999","unstructured":"Gironacci, M. M., Coba, M. P. & Pena, C. Angiotensin-(1\u20137) binds at the type 1 angiotensin II receptors in rat renal cortex. Regul. Pept. 84, 51\u201354 (1999).","journal-title":"Regul. Pept."},{"key":"BFnrcardio201459_CR67","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/CS20110036","volume":"121","author":"S Bosnyak","year":"2011","unstructured":"Bosnyak, S. et al. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin. Sci. (Lond.) 121, 297\u2013303 (2011).","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnrcardio201459_CR68","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1042\/BJ20051455","volume":"395","author":"S Lara Lda","year":"2006","unstructured":"Lara Lda, S. et al. Involvement of the Gi\/o\/cGMP\/PKG pathway in the AT2-mediated inhibition of outer cortex proximal tubule Na+-ATPase by Ang-(1\u20137). Biochem. J. 395, 183\u2013190 (2006).","journal-title":"Biochem. J."},{"key":"BFnrcardio201459_CR69","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1161\/01.HYP.0000160325.59323.b8","volume":"45","author":"PE Walters","year":"2005","unstructured":"Walters, P. E., Gaspari, T. A. & Widdop, R. E. Angiotensin-(1\u20137) acts as a vasodepressor agent via angiotensin II type 2 receptors in conscious rats. Hypertension 45, 960\u2013966 (2005).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR70","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/0092-8674(86)90785-3","volume":"45","author":"D Young","year":"1986","unstructured":"Young, D., Waitches, G., Birchmeier, C., Fasano, O. & Wigler, M. Isolation and characterization of a new cellular oncogene encoding a protein with multiple potential transmembrane domains. Cell 45, 711\u2013719 (1986).","journal-title":"Cell"},{"key":"BFnrcardio201459_CR71","doi-asserted-by":"publisher","first-page":"8258","DOI":"10.1073\/pnas.1432869100","volume":"100","author":"RA Santos","year":"2003","unstructured":"Santos, R. A. et al. Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas. Proc. Natl Acad. Sci. USA 100, 8258\u20138263 (2003).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio201459_CR72","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/0014-5793(94)01292-9","volume":"357","author":"R Metzger","year":"1995","unstructured":"Metzger, R. et al. Expression of the mouse and rat mas proto-oncogene in the brain and peripheral tissues. FEBS Lett. 357, 27\u201332 (1995).","journal-title":"FEBS Lett."},{"key":"BFnrcardio201459_CR73","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1113\/expphysiol.2007.040345","volume":"93","author":"N Alenina","year":"2008","unstructured":"Alenina, N., Xu, P., Rentzsch, B., Patkin, E. L. & Bader, M. Genetically altered animal models for Mas and angiotensin-(1\u20137). Exp. Physiol. 93, 528\u2013537 (2008).","journal-title":"Exp. Physiol."},{"key":"BFnrcardio201459_CR74","doi-asserted-by":"publisher","first-page":"5339","DOI":"10.1073\/pnas.85.14.5339","volume":"85","author":"D Young","year":"1988","unstructured":"Young, D., O'Neill, K., Jessell, T. & Wigler, M. Characterization of the rat mas oncogene and its high-level expression in the hippocampus and cerebral cortex of rat brain. Proc. Natl Acad. Sci. USA 85, 5339\u20135342 (1988).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio201459_CR75","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1161\/01.HYP.0000215289.51180.5c","volume":"47","author":"RA Santos","year":"2006","unstructured":"Santos, R. A. et al. Impairment of in vitro and in vivo heart function in angiotensin-(1\u20137) receptor MAS knockout mice. Hypertension 47, 996\u20131002 (2006).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR76","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1177\/1470320311402109","volume":"12","author":"Z Tan","year":"2011","unstructured":"Tan, Z., Wu, J. & Ma, H. Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1\u20137) in heart and kidney of spontaneously hypertensive rats. J. Renin Angiotensin Aldosterone Syst. 12, 413\u2013419 (2011).","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"BFnrcardio201459_CR77","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.peptides.2012.03.022","volume":"35","author":"MF Dias-Peixoto","year":"2012","unstructured":"Dias-Peixoto, M. F. et al. The cardiac expression of Mas receptor is responsive to different physiological and pathological stimuli. Peptides 35, 196\u2013201 (2012).","journal-title":"Peptides"},{"key":"BFnrcardio201459_CR78","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/00001756-199612200-00019","volume":"8","author":"M Kumar","year":"1996","unstructured":"Kumar, M., Grammas, P., Giacomelli, F. & Wiener, J. Selective expression of c-mas proto-oncogene in rat cerebral endothelial cells. Neuroreport 8, 93\u201396 (1996).","journal-title":"Neuroreport"},{"key":"BFnrcardio201459_CR79","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S0022-3565(24)37208-8","volume":"284","author":"MM Muthalif","year":"1998","unstructured":"Muthalif, M. M., Benter, I. F., Uddin, M. R., Harper, J. L. & Malik, K. U. Signal transduction mechanisms involved in angiotensin-(1\u20137)-stimulated arachidonic acid release and prostanoid synthesis in rabbit aortic smooth muscle cells. J. Pharmacol. Exp. Ther. 284, 388\u2013398 (1998).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrcardio201459_CR80","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1161\/01.HYP.28.1.104","volume":"28","author":"EJ Freeman","year":"1996","unstructured":"Freeman, E. J., Chisolm, G. M., Ferrario, C. M. & Tallant, E. A. Angiotensin-(1\u20137) inhibits vascular smooth muscle cell growth. Hypertension 28, 104\u2013108 (1996).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR81","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.jash.2008.05.003","volume":"2","author":"LA Rabelo","year":"2008","unstructured":"Rabelo, L. A. et al. Ablation of angiotensin (1\u20137) receptor Mas in C57Bl\/6 mice causes endothelial dysfunction. J. Am. Soc. Hypertens. 2, 418\u2013424 (2008).","journal-title":"J. Am. Soc. Hypertens."},{"key":"BFnrcardio201459_CR82","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1097\/HJH.0b013e3282f0143c","volume":"25","author":"C Peir\u00f3","year":"2007","unstructured":"Peir\u00f3, C. et al. Endothelial dysfunction through genetic deletion or inhibition of the G protein-coupled receptor Mas: a new target to improve endothelial function. J. Hypertens. 25, 2421\u20132425 (2007).","journal-title":"J. Hypertens."},{"key":"BFnrcardio201459_CR83","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/ki.2009.61","volume":"75","author":"SV Pinheiro","year":"2009","unstructured":"Pinheiro, S. V. et al. Genetic deletion of the angiotensin-(1\u20137) receptor Mas leads to glomerular hyperfiltration and microalbuminuria. Kidney Int. 75, 1184\u20131193 (2009).","journal-title":"Kidney Int."},{"key":"BFnrcardio201459_CR84","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1159\/000320689","volume":"33","author":"D Rakusan","year":"2010","unstructured":"Rakusan, D. et al. Knockout of angiotensin 1\u20137 receptor Mas worsens the course of two-kidney, one-clip Goldblatt hypertension: roles of nitric oxide deficiency and enhanced vascular responsiveness to angiotensin II. Kidney Blood Press Res. 33, 476\u2013488 (2010).","journal-title":"Kidney Blood Press Res."},{"key":"BFnrcardio201459_CR85","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ejphar.2012.05.025","volume":"689","author":"S Heringer-Walther","year":"2012","unstructured":"Heringer-Walther, S. et al. The genetic deletion of Mas abolishes salt induced hypertension in mice. Eur. J. Pharmacol. 689, 147\u2013153 (2012).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnrcardio201459_CR86","doi-asserted-by":"publisher","first-page":"R804","DOI":"10.1152\/ajpregu.00222.2010","volume":"300","author":"P Xu","year":"2011","unstructured":"Xu, P., Sriramula, S. & Lazartigues, E. ACE2\/ANG-(1\u20137)\/Mas pathway in the brain: the axis of good. Am. J. Physiol. Regul. Integr. Comp. Physiol. 300, R804\u2013R817 (2011).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrcardio201459_CR87","doi-asserted-by":"publisher","first-page":"F1297","DOI":"10.1152\/ajprenal.00110.2010","volume":"298","author":"CM Ferrario","year":"2010","unstructured":"Ferrario, C. M. & Varagic, J. The ANG-(1\u20137)\/ACE2\/mas axis in the regulation of nephron function. Am. J. Physiol. Renal Physiol. 298, F1297\u2013F1305 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrcardio201459_CR88","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/hr.2009.74","volume":"32","author":"M Iwai","year":"2009","unstructured":"Iwai, M. & Horiuchi, M. Devil and angel in the renin-angiotensin system: ACE-angiotensin II-AT1 receptor axis vs. ACE2-angiotensin-(1\u20137)-Mas receptor axis. Hypertens. Res. 32, 533\u2013536 (2009).","journal-title":"Hypertens. Res."},{"key":"BFnrcardio201459_CR89","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1128\/MCB.18.3.1225","volume":"18","author":"IE Zohn","year":"1998","unstructured":"Zohn, I. E., Symons, M., Chrzanowska-Wodnicka, M., Westwick, J. K. & Der, C. J. Mas oncogene signaling and transformation require the small GTP-binding protein Rac. Mol. Cell Biol. 18, 1225\u20131235 (1998).","journal-title":"Mol. Cell Biol."},{"key":"BFnrcardio201459_CR90","doi-asserted-by":"publisher","first-page":"2045","DOI":"10.1093\/carcin\/bgh236","volume":"25","author":"PE Gallagher","year":"2004","unstructured":"Gallagher, P. E. & Tallant, E. A. Inhibition of human lung cancer cell growth by angiotensin-(1\u20137). Carcinogenesis 25, 2045\u20132052 (2004).","journal-title":"Carcinogenesis"},{"key":"BFnrcardio201459_CR91","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/pros.22540","volume":"73","author":"B Krishnan","year":"2013","unstructured":"Krishnan, B., Torti, F. M., Gallagher, P. E. & Tallant, E. A. Angiotensin-(1\u20137) reduces proliferation and angiogenesis of human prostate cancer xenografts with a decrease in angiogenic factors and an increase in sFlt-1. Prostate 73, 60\u201370 (2013).","journal-title":"Prostate"},{"key":"BFnrcardio201459_CR92","doi-asserted-by":"publisher","first-page":"16757","DOI":"10.1074\/jbc.M601121200","volume":"281","author":"M Canals","year":"2006","unstructured":"Canals, M., Jenkins, L., Kellett, E. & Milligan, G. Up-regulation of the angiotensin II type 1 receptor by the MAS proto-oncogene is due to constitutive activation of Gq\/G11 by MAS. J. Biol. Chem. 281, 16757\u201316767 (2006).","journal-title":"J. Biol. Chem."},{"key":"BFnrcardio201459_CR93","doi-asserted-by":"publisher","first-page":"H299","DOI":"10.1152\/ajpheart.00723.2011","volume":"302","author":"T Zhang","year":"2012","unstructured":"Zhang, T. et al. Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 302, H299\u2013H311 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR94","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0014-2999(01)00791-9","volume":"414","author":"D Chansel","year":"2001","unstructured":"Chansel, D., Vandermeersch, S., Oko, A., Curat, C. & Ardaillou, R. Effects of angiotensin IV and angiotensin-(1\u20137) on basal and angiotensin II-stimulated cytosolic Ca2+ in mesangial cells. Eur. J. Pharmacol. 414, 165\u2013175 (2001).","journal-title":"Eur. J. Pharmacol."},{"key":"BFnrcardio201459_CR95","first-page":"III126","volume":"18","author":"CM Ferrario","year":"1991","unstructured":"Ferrario, C. M. et al. Angiotensin-(1\u20137): a new hormone of the angiotensin system. Hypertension 18, III126\u2013III133 (1991).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR96","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/cvr\/cvt065","volume":"99","author":"EJ Tassone","year":"2013","unstructured":"Tassone, E. J. et al. Angiotensin (1\u20137) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs. Cardiovasc. Res. 99, 129\u2013136 (2013).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio201459_CR97","doi-asserted-by":"publisher","first-page":"1806","DOI":"10.1161\/01.CIR.0000160867.23556.7D","volume":"111","author":"E Kostenis","year":"2005","unstructured":"Kostenis, E. et al. G.-protein-coupled receptor Mas is a physiological antagonist of the angiotensin II type 1 receptor. Circulation 111, 1806\u20131813 (2005).","journal-title":"Circulation"},{"key":"BFnrcardio201459_CR98","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1124\/pr.112.007179","volume":"65","author":"AP Davenport","year":"2013","unstructured":"Davenport, A. P. et al. International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. Pharmacol. Rev. 65, 967\u2013986 (2013).","journal-title":"Pharmacol. Rev."},{"key":"BFnrcardio201459_CR99","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/0361-9230(94)90104-X","volume":"35","author":"RA Santos","year":"1994","unstructured":"Santos, R. A. et al. Characterization of a new angiotensin antagonist selective for angiotensin-(1\u20137): evidence that the actions of angiotensin-(1\u20137) are mediated by specific angiotensin receptors. Brain Res. Bull. 35, 293\u2013298 (1994).","journal-title":"Brain Res. Bull."},{"key":"BFnrcardio201459_CR100","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1161\/01.HYP.0000052947.60363.24","volume":"41","author":"RA Santos","year":"2003","unstructured":"Santos, R. A. et al. Characterization of a new selective antagonist for angiotensin-(1\u20137), D-pro7-angiotensin-(1\u20137). Hypertension 41, 737\u2013743 (2003).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR101","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1161\/01.HYP.0000037979.53963.8F","volume":"40","author":"G Wiemer","year":"2002","unstructured":"Wiemer, G., Dobrucki, L. W., Louka, F. R., Malinski, T. & Heitsch, H. AVE 0991, a nonpeptide mimic of the effects of angiotensin-(1\u20137) on the endothelium. Hypertension 40, 847\u2013852 (2002).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR102","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/01.HYP.0000141438.64887.42","volume":"44","author":"SV Pinheiro","year":"2004","unstructured":"Pinheiro, S. V. et al. Nonpeptide AVE 0991 is an angiotensin-(1\u20137) receptor Mas agonist in the mouse kidney. Hypertension 44, 490\u2013496 (2004).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR103","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1161\/HYPERTENSIONAHA.110.152942","volume":"56","author":"SQ Savergnini","year":"2010","unstructured":"Savergnini, S. Q. et al. Vascular relaxation, antihypertensive effect, and cardioprotection of a novel peptide agonist of the MAS receptor. Hypertension 56, 112\u2013120 (2010).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR104","doi-asserted-by":"publisher","first-page":"2218","DOI":"10.1172\/JCI16980","volume":"116","author":"SB Gurley","year":"2006","unstructured":"Gurley, S. B. et al. Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. J. Clin. Invest. 116, 2218\u20132225 (2006).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio201459_CR105","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1161\/01.HYP.0000259942.38108.20","volume":"49","author":"M Yamazato","year":"2007","unstructured":"Yamazato, M., Yamazato, Y., Sun, C., Diez-Freire, C. & Raizada, M. K. Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension 49, 926\u2013931 (2007).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR106","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1093\/cvr\/cvr242","volume":"92","author":"S Sriramula","year":"2011","unstructured":"Sriramula, S., Cardinale, J. P., Lazartigues, E. & Francis, J. ACE2 overexpression in the paraventricular nucleus attenuates angiotensin II-induced hypertension. Cardiovasc. Res. 92, 401\u2013408 (2011).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio201459_CR107","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1161\/CIRCRESAHA.107.169110","volume":"102","author":"Y Feng","year":"2008","unstructured":"Feng, Y. et al. Angiotensin-converting enzyme 2 overexpression in the subfornical organ prevents the angiotensin II-mediated pressor and drinking responses and is associated with angiotensin II type 1 receptor downregulation. Circ. Res. 102, 729\u2013736 (2008).","journal-title":"Circ. Res."},{"key":"BFnrcardio201459_CR108","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1161\/CIRCRESAHA.109.208645","volume":"106","author":"Y Feng","year":"2010","unstructured":"Feng, Y. et al. Brain-selective overexpression of human Angiotensin-converting enzyme type 2 attenuates neurogenic hypertension. Circ. Res. 106, 373\u2013382 (2010).","journal-title":"Circ. Res."},{"key":"BFnrcardio201459_CR109","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1161\/HYPERTENSIONAHA.108.114322","volume":"52","author":"B Rentzsch","year":"2008","unstructured":"Rentzsch, B. et al. Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension 52, 967\u2013973 (2008).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR110","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/HYPERTENSIONAHA.109.138420","volume":"55","author":"J Wysocki","year":"2010","unstructured":"Wysocki, J. et al. Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Hypertension 55, 90\u201398 (2010).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR111","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1113\/expphysiol.2012.067165","volume":"98","author":"J Lo","year":"2013","unstructured":"Lo, J. et al. Angiotensin-converting enzyme 2 antagonizes angiotensin II-induced pressor response and NADPH oxidase activation in Wistar-Kyoto rats and spontaneously hypertensive rats. Exp. Physiol. 98, 109\u2013122 (2013).","journal-title":"Exp. Physiol."},{"key":"BFnrcardio201459_CR112","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/01.HYP.30.3.542","volume":"30","author":"CV Lima","year":"1997","unstructured":"Lima, C. V., Paula, R. D., Resende, F. L., Khosla, M. C. & Santos, R. A. Potentiation of the hypotensive effect of bradykinin by short-term infusion of angiotensin-(1\u20137) in normotensive and hypertensive rats. Hypertension 30, 542\u2013548 (1997).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR113","first-page":"R89","volume":"263","author":"MJ Campagnole-Santos","year":"1992","unstructured":"Campagnole-Santos, M. J., Heringer, S. B., Batista, E. N., Khosla, M. C. & Santos, R. A. Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. Am. J. Physiol. 263, R89\u2013R94 (1992).","journal-title":"Am. J. Physiol."},{"key":"BFnrcardio201459_CR114","doi-asserted-by":"publisher","first-page":"H1985","DOI":"10.1152\/ajpheart.01145.2002","volume":"284","author":"WO Sampaio","year":"2003","unstructured":"Sampaio, W. O., Nascimento, A. A. & Santos, R. A. Systemic and regional hemodynamic effects of angiotensin-(1\u20137) in rats. Am. J. Physiol. Heart Circ. Physiol. 284, H1985\u2013H1994 (2003).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR115","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0196-9781(01)00579-4","volume":"23","author":"MA Bayorh","year":"2002","unstructured":"Bayorh, M. A. et al. 1A-779 attenuates angiotensin-(1\u20137) depressor response in salt-induced hypertensive rats. Peptides 23, 57\u201364 (2002).","journal-title":"Peptides"},{"key":"BFnrcardio201459_CR116","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1161\/01.HYP.30.2.217","volume":"30","author":"A Abbas","year":"1997","unstructured":"Abbas, A., Gorelik, G., Carbini, L. A. & Scicli, A. G. Angiotensin-(1\u20137) induces bradykinin-mediated hypotensive responses in anesthetized rats. Hypertension 30, 217\u2013221 (1997).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR117","first-page":"H313","volume":"269","author":"IF Benter","year":"1995","unstructured":"Benter, I. F., Ferrario, C. M., Morris, M. & Diz, D. I. Antihypertensive actions of angiotensin-(1\u20137) in spontaneously hypertensive rats. Am. J. Physiol. 269, H313\u2013H319 (1995).","journal-title":"Am. J. Physiol."},{"key":"BFnrcardio201459_CR118","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/S0196-9781(01)00404-1","volume":"22","author":"D Eatman","year":"2001","unstructured":"Eatman, D. et al. Gender differences in the attenuation of salt-induced hypertension by angiotensin (1\u20137). Peptides 22, 927\u2013933 (2001).","journal-title":"Peptides"},{"key":"BFnrcardio201459_CR119","doi-asserted-by":"publisher","first-page":"H2417","DOI":"10.1152\/ajpheart.01170.2005","volume":"290","author":"JL Grobe","year":"2006","unstructured":"Grobe, J. L., Mecca, A. P., Mao, H. & Katovich, M. J. Chronic angiotensin-(1\u20137) prevents cardiac fibrosis in DOCA-salt model of hypertension. Am. J. Physiol. Heart Circ. Physiol. 290, H2417\u2013H2423 (2006).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR120","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1097\/HJH.0b013e32832f0d06","volume":"27","author":"M Burgelova","year":"2009","unstructured":"Burgelova, M. et al. Impairment of the angiotensin-converting enzyme 2-angiotensin-(1\u20137)-Mas axis contributes to the acceleration of two-kidney, one-clip Goldblatt hypertension. J. Hypertens. 27, 1988\u20132000 (2009).","journal-title":"J. Hypertens."},{"key":"BFnrcardio201459_CR121","doi-asserted-by":"publisher","first-page":"H2372","DOI":"10.1152\/ajpheart.00846.2011","volume":"302","author":"A Shah","year":"2012","unstructured":"Shah, A., Oh, Y. B., Lee, S. H., Lim, J. M. & Kim, S. H. Angiotensin-(1\u20137) attenuates hypertension in exercise-trained renal hypertensive rats. Am. J. Physiol. Heart Circ. Physiol. 302, H2372\u2013H2380 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR122","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1042\/CS20100280","volume":"120","author":"E Velkoska","year":"2011","unstructured":"Velkoska, E., Dean, R. G., Griggs, K., Burchill, L. & Burrell, L. M. Angiotensin-(1\u20137) infusion is associated with increased blood pressure and adverse cardiac remodelling in rats with subtotal nephrectomy. Clin. Sci. (Lond.) 120, 335\u2013345 (2011).","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnrcardio201459_CR123","first-page":"R786","volume":"267","author":"A Moriguchi","year":"1994","unstructured":"Moriguchi, A., Ferrario, C. M., Brosnihan, K. B., Ganten, D. & Morris, M. Differential regulation of central vasopressin in transgenic rats harboring the mouse Ren-2 gene. Am. J. Physiol. 267, R786\u2013R791 (1994).","journal-title":"Am. J. Physiol."},{"key":"BFnrcardio201459_CR124","doi-asserted-by":"publisher","first-page":"H393","DOI":"10.1152\/ajpheart.00075.2012","volume":"303","author":"PS Guimaraes","year":"2012","unstructured":"Guimaraes, P. S. et al. Chronic infusion of angiotensin-(1\u20137) into the lateral ventricle of the brain attenuates hypertension in DOCA-salt rats. Am. J. Physiol. Heart Circ. Physiol. 303, H393\u2013H400 (2012).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR125","doi-asserted-by":"publisher","first-page":"H699","DOI":"10.1152\/ajpheart.00193.2013","volume":"305","author":"B Xue","year":"2013","unstructured":"Xue, B. et al. Central endogenous angiotensin-(1\u20137) protects against aldosterone\/NaCl-induced hypertension in female rats. Am. J. Physiol. Heart Circ. Physiol. 305, H699\u2013H705 (2013).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR126","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3109\/10641963.2011.583967","volume":"33","author":"T Nakagaki","year":"2011","unstructured":"Nakagaki, T. et al. Role of angiotensin-(1\u20137) in rostral ventrolateral medulla in blood pressure regulation via sympathetic nerve activity in Wistar-Kyoto and spontaneous hypertensive rats. Clin. Exp. Hypertens. 33, 223\u2013230 (2011).","journal-title":"Clin. Exp. Hypertens."},{"key":"BFnrcardio201459_CR127","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1161\/01.HYP.27.6.1284","volume":"27","author":"DR Oliveira","year":"1996","unstructured":"Oliveira, D. R., Santos, R. A., Santos, G. F., Khosla, M. & Campagnole-Santos, M. J. Changes in the baroreflex control of heart rate produced by central infusion of selective angiotensin antagonists in hypertensive rats. Hypertension 27, 1284\u20131290 (1996).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR128","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0167-0115(98)00038-X","volume":"74","author":"AC Simoes e Silva","year":"1998","unstructured":"Simoes e Silva, A. C., Bello, A. P., Baracho, N. C., Khosla, M. C. & Santos, R. A. Diuresis and natriuresis produced by long term administration of a selective angiotensin-(1\u20137) antagonist in normotensive and hypertensive rats. Regul. Pept. 74, 177\u2013184 (1998).","journal-title":"Regul. Pept."},{"key":"BFnrcardio201459_CR129","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1161\/01.HYP.30.3.549","volume":"30","author":"RR Britto","year":"1997","unstructured":"Britto, R. R., Santos, R. A., Fagundes-Moura, C. R., Khosla, M. C. & Campagnole-Santos, M. J. Role of angiotensin-(1\u20137) in the modulation of the baroreflex in renovascular hypertensive rats. Hypertension 30, 549\u2013556 (1997).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR130","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1161\/01.HYP.31.2.699","volume":"31","author":"SN Iyer","year":"1998","unstructured":"Iyer, S. N., Chappell, M. C., Averill, D. B., Diz, D. I. & Ferrario, C. M. Vasodepressor actions of angiotensin-(1\u20137) unmasked during combined treatment with lisinopril and losartan. Hypertension 31, 699\u2013705 (1998).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR131","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/01.HYP.38.1.90","volume":"38","author":"S Sasaki","year":"2001","unstructured":"Sasaki, S. et al. Effects of angiotensin-(1\u20137) on forearm circulation in normotensive subjects and patients with essential hypertension. Hypertension 38, 90\u201394 (2001).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR132","doi-asserted-by":"publisher","first-page":"R981","DOI":"10.1152\/ajpregu.00263.2003","volume":"285","author":"RR Plovsing","year":"2003","unstructured":"Plovsing, R. R. et al. Effects of truncated angiotensins in humans after double blockade of the renin system. Am. J. Physiol. Regul. Integr. Comp. Physiol. 285, R981\u2013R991 (2003).","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"BFnrcardio201459_CR133","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1113\/expphysiol.2007.040204","volume":"93","author":"A Zulli","year":"2008","unstructured":"Zulli, A., Rai, S., Buxton, B. F., Burrell, L. M. & Hare, D. L. Co-localization of angiotensin-converting enzyme 2-, octomer-4- and CD34-positive cells in rabbit atherosclerotic plaques. Exp. Physiol. 93, 564\u2013569 (2008).","journal-title":"Exp. Physiol."},{"key":"BFnrcardio201459_CR134","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.carpath.2012.05.004","volume":"22","author":"KR Purushothaman","year":"2013","unstructured":"Purushothaman, K. R. et al. Expression of angiotensin-converting enzyme 2 and its end product angiotensin 1\u20137 is increased in diabetic atheroma: implications for inflammation and neovascularization. Cardiovasc. Pathol. 22, 42\u201348 (2013).","journal-title":"Cardiovasc. Pathol."},{"key":"BFnrcardio201459_CR135","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1002\/path.2357","volume":"215","author":"JC Sluimer","year":"2008","unstructured":"Sluimer, J. C. et al. Angiotensin-converting enzyme 2 (ACE2) expression and activity in human carotid atherosclerotic lesions. J. Pathol. 215, 273\u2013279 (2008).","journal-title":"J. Pathol."},{"key":"BFnrcardio201459_CR136","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.atherosclerosis.2012.08.018","volume":"226","author":"Y Wang","year":"2013","unstructured":"Wang, Y., Tikellis, C., Thomas, M. C. & Golledge, J. Angiotensin converting enzyme 2 and atherosclerosis. Atherosclerosis 226, 3\u20138 (2013).","journal-title":"Atherosclerosis"},{"key":"BFnrcardio201459_CR137","doi-asserted-by":"publisher","first-page":"H1377","DOI":"10.1152\/ajpheart.00331.2008","volume":"295","author":"F Lovren","year":"2008","unstructured":"Lovren, F. et al. Angiotensin converting enzyme-2 confers endothelial protection and attenuates atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. 295, H1377\u2013H1384 (2008).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR138","doi-asserted-by":"publisher","first-page":"15886","DOI":"10.1073\/pnas.1001253107","volume":"107","author":"C Zhang","year":"2010","unstructured":"Zhang, C. et al. Angiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cells. Proc. Natl Acad. Sci. USA 107, 15886\u201315891 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrcardio201459_CR139","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1161\/ATVBAHA.108.164715","volume":"28","author":"B Dong","year":"2008","unstructured":"Dong, B. et al. Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28, 1270\u20131276 (2008).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201459_CR140","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1161\/CIRCRESAHA.110.219279","volume":"107","author":"MC Thomas","year":"2010","unstructured":"Thomas, M. C. et al. Genetic Ace2 deficiency accentuates vascular inflammation and atherosclerosis in the ApoE knockout mouse. Circ. Res. 107, 888\u2013897 (2010).","journal-title":"Circ. Res."},{"key":"BFnrcardio201459_CR141","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1161\/ATVBAHA.110.221614","volume":"31","author":"SE Thatcher","year":"2011","unstructured":"Thatcher, S. E. et al. Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor\u2212\/\u2212 mice. Arterioscler. Thromb. Vasc. Biol. 31, 758\u2013765 (2011).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201459_CR142","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1093\/cvr\/cvt245","volume":"101","author":"M Sahara","year":"2014","unstructured":"Sahara, M. et al. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation. Cardiovasc. Res. 101, 236\u2013246 (2014).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio201459_CR143","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1161\/ATVBAHA.110.204453","volume":"30","author":"S Tesanovic","year":"2010","unstructured":"Tesanovic, S., Vinh, A., Gaspari, T. A., Casley, D. & Widdop, R. E. Vasoprotective and atheroprotective effects of angiotensin (1\u20137) in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 30, 1606\u20131613 (2010).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201459_CR144","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1161\/ATVBAHA.113.301320","volume":"33","author":"JM Yang","year":"2013","unstructured":"Yang, J. M. et al. Angiotensin-(1\u20137) dose-dependently inhibits atherosclerotic lesion formation and enhances plaque stability by targeting vascular cells. Arterioscler. Thromb. Vasc. Biol. 33, 1978\u20131985 (2013).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"BFnrcardio201459_CR145","first-page":"181","volume":"61","author":"J Toton-Zuranska","year":"2010","unstructured":"Toton-Zuranska, J. et al. AVE 0991-angiotensin-(1\u20137) receptor agonist, inhibits atherogenesis in apoE-knockout mice. J. Physiol. Pharmacol. 61, 181\u2013183 (2010).","journal-title":"J. Physiol. Pharmacol."},{"key":"BFnrcardio201459_CR146","first-page":"77","volume":"63","author":"J Jawien","year":"2012","unstructured":"Jawien, J. et al. Angiotensin-(1\u20137) receptor Mas agonist ameliorates progress of atherosclerosis in apoE-knockout mice. J. Physiol. Pharmacol. 63, 77\u201385 (2012).","journal-title":"J. Physiol. Pharmacol."},{"key":"BFnrcardio201459_CR147","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.bbrc.2012.11.098","volume":"430","author":"F Zhang","year":"2013","unstructured":"Zhang, F., Ren, J., Chan, K. & Chen, H. Angiotensin-(1\u20137) regulates angiotensin II-induced VCAM-1 expression on vascular endothelial cells. Biochem. Biophys. Res. Commun. 430, 642\u2013646 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"BFnrcardio201459_CR148","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/1741-7015-2-19","volume":"2","author":"AB Goulter","year":"2004","unstructured":"Goulter, A. B., Goddard, M. J., Allen, J. C. & Clark, K. L. ACE2 gene expression is up-regulated in the human failing heart. BMC Med. 2, 19 (2004).","journal-title":"BMC Med."},{"key":"BFnrcardio201459_CR149","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.ijcard.2009.11.057","volume":"145","author":"M Ohtsuki","year":"2010","unstructured":"Ohtsuki, M. et al. Angiotensin converting enzyme 2 gene expression increased compensatory for left ventricular remodeling in patients with end-stage heart failure. Int. J. Cardiol. 145, 333\u2013334 (2010).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio201459_CR150","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1152\/physiolgenomics.00255.2004","volume":"21","author":"MM Kittleson","year":"2005","unstructured":"Kittleson, M. M. et al. Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol. Genomics 21, 299\u2013307 (2005).","journal-title":"Physiol. Genomics"},{"key":"BFnrcardio201459_CR151","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.healun.2006.04.012","volume":"25","author":"M Batlle","year":"2006","unstructured":"Batlle, M. et al. Increased expression of the renin-angiotensin system and mast cell density but not of angiotensin-converting enzyme II in late stages of human heart failure. J. Heart Lung Transplant 25, 1117\u20131125 (2006).","journal-title":"J. Heart Lung Transplant"},{"key":"BFnrcardio201459_CR152","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cardfail.2009.09.005","volume":"16","author":"Y Wang","year":"2010","unstructured":"Wang, Y. et al. Plasma ACE2 activity is an independent prognostic marker in Chagas' disease and equally potent as BNP. J. Card. Fail. 16, 157\u2013163 (2010).","journal-title":"J. Card. Fail."},{"key":"BFnrcardio201459_CR153","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s00109-005-0718-5","volume":"84","author":"W Lieb","year":"2006","unstructured":"Lieb, W. et al. Association of angiotensin-converting enzyme 2 (ACE2) gene polymorphisms with parameters of left ventricular hypertrophy in men. Results of the MONICA Augsburg echocardiographic substudy. J. Mol. Med. (Berl.) 84, 88\u201396 (2006).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFnrcardio201459_CR154","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00439-008-0524-6","volume":"124","author":"L van der Merwe","year":"2008","unstructured":"van der Merwe, L. et al. Genetic variation in angiotensin-converting enzyme 2 gene is associated with extent of left ventricular hypertrophy in hypertrophic cardiomyopathy. Hum. Genet. 124, 57\u201361 (2008).","journal-title":"Hum. Genet."},{"key":"BFnrcardio201459_CR155","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1113\/expphysiol.2005.031096","volume":"90","author":"MJ Huentelman","year":"2005","unstructured":"Huentelman, M. J. et al. Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. Exp. Physiol. 90, 783\u2013790 (2005).","journal-title":"Exp. Physiol."},{"key":"BFnrcardio201459_CR156","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jacc.2011.09.071","volume":"59","author":"B Dong","year":"2012","unstructured":"Dong, B. et al. Angiotensin-converting enzyme-2 overexpression improves left ventricular remodeling and function in a rat model of diabetic cardiomyopathy. J. Am. Coll. Cardiol. 59, 739\u2013747 (2012).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201459_CR157","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1089\/hum.2009.160","volume":"21","author":"YX Zhao","year":"2010","unstructured":"Zhao, Y. X. et al. ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction. Hum. Gene Ther. 21, 1545\u20131554 (2010).","journal-title":"Hum. Gene Ther."},{"key":"BFnrcardio201459_CR158","doi-asserted-by":"publisher","first-page":"e20828","DOI":"10.1371\/journal.pone.0020828","volume":"6","author":"JA Johnson","year":"2011","unstructured":"Johnson, J. A., West, J., Maynard, K. B. & Hemnes, A. R. ACE2 improves right ventricular function in a pressure overload model. PLoS ONE 6, e20828 (2011).","journal-title":"PLoS ONE"},{"key":"BFnrcardio201459_CR159","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cardiores.2007.04.007","volume":"75","author":"GY Oudit","year":"2007","unstructured":"Oudit, G. Y. et al. Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice. Cardiovasc. Res. 75, 29\u201339 (2007).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio201459_CR160","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","volume":"122","author":"J Zhong","year":"2010","unstructured":"Zhong, J. et al. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation 122, 717\u2013728 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio201459_CR161","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1093\/cvr\/cvr036","volume":"91","author":"S Bodiga","year":"2011","unstructured":"Bodiga, S. et al. Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47(phox) NADPH oxidase subunit. Cardiovasc. Res. 91, 151\u2013161 (2011).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio201459_CR162","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1161\/01.HYP.0000205833.89478.5b","volume":"47","author":"K Yamamoto","year":"2006","unstructured":"Yamamoto, K. et al. Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension 47, 718\u2013726 (2006).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR163","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1161\/CIRCRESAHA.112.268029","volume":"110","author":"VB Patel","year":"2012","unstructured":"Patel, V. B. et al. Loss of angiotensin-converting enzyme-2 exacerbates diabetic cardiovascular complications and leads to systolic and vascular dysfunction: a critical role of the angiotensin II\/AT1 receptor axis. Circ. Res. 110, 1322\u20131335 (2012).","journal-title":"Circ. Res."},{"key":"BFnrcardio201459_CR164","doi-asserted-by":"publisher","first-page":"e48910","DOI":"10.1371\/journal.pone.0048910","volume":"7","author":"Y Feng","year":"2012","unstructured":"Feng, Y., Hans, C., McIlwain, E., Varner, K. J. & Lazartigues, E. Angiotensin-converting enzyme 2 over-expression in the central nervous system reduces angiotensin-II-mediated cardiac hypertrophy. PLoS ONE 7, e48910 (2012).","journal-title":"PLoS ONE"},{"key":"BFnrcardio201459_CR165","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1161\/01.CIR.0000092888.63239.54","volume":"108","author":"DB Averill","year":"2003","unstructured":"Averill, D. B., Ishiyama, Y., Chappell, M. C. & Ferrario, C. M. Cardiac angiotensin-(1\u20137) in ischemic cardiomyopathy. Circulation 108, 2141\u20132146 (2003).","journal-title":"Circulation"},{"key":"BFnrcardio201459_CR166","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1161\/01.CIR.0000013847.07035.B9","volume":"105","author":"AE Loot","year":"2002","unstructured":"Loot, A. E. et al. Angiotensin-(1\u20137) attenuates the development of heart failure after myocardial infarction in rats. Circulation 105, 1548\u20131550 (2002).","journal-title":"Circulation"},{"key":"BFnrcardio201459_CR167","doi-asserted-by":"publisher","first-page":"H1113","DOI":"10.1152\/ajpheart.00828.2006","volume":"292","author":"AJ Ferreira","year":"2007","unstructured":"Ferreira, A. J. et al. The nonpeptide angiotensin-(1\u20137) receptor Mas agonist AVE-0991 attenuates heart failure induced by myocardial infarction. Am. J. Physiol. Heart Circ. Physiol. 292, H1113\u2013H1119 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR168","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/CIRCHEARTFAILURE.113.000672","volume":"7","author":"J Mori","year":"2014","unstructured":"Mori, J. et al. Angiotensin 1\u20137 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db\/db mice by reducing lipotoxicity and inflammation. Circ. Heart Fail. 7, 327\u2013339 (2014).","journal-title":"Circ. Heart Fail."},{"key":"BFnrcardio201459_CR169","doi-asserted-by":"publisher","first-page":"H736","DOI":"10.1152\/ajpheart.00937.2006","volume":"292","author":"JL Grobe","year":"2007","unstructured":"Grobe, J. L. et al. Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1\u20137). Am. J. Physiol. Heart Circ. Physiol. 292, H736\u2013H742 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR170","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1152\/physiolgenomics.00227.2003","volume":"17","author":"RA Santos","year":"2004","unstructured":"Santos, R. A. et al. Expression of an angiotensin-(1\u20137)-producing fusion protein produces cardioprotective effects in rats. Physiol. Genomics 17, 292\u2013299 (2004).","journal-title":"Physiol. Genomics"},{"key":"BFnrcardio201459_CR171","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.jash.2008.04.012","volume":"2","author":"AP Nadu","year":"2008","unstructured":"Nadu, A. P., Ferreira, A. J., Reudelhuber, T. L., Bader, M. & Santos, R. A. Reduced isoproterenol-induced renin-angiotensin changes and extracellular matrix deposition in hearts of TGR(A1\u20137)3292 rats. J. Am. Soc. Hypertens. 2, 341\u2013348 (2008).","journal-title":"J. Am. Soc. Hypertens."},{"key":"BFnrcardio201459_CR172","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1161\/HYPERTENSIONAHA.112.191650","volume":"59","author":"VB Patel","year":"2012","unstructured":"Patel, V. B. et al. Cardioprotective effects mediated by angiotensin II type 1 receptor blockade and enhancing angiotensin 1\u20137 in experimental heart failure in angiotensin-converting enzyme 2-null mice. Hypertension 59, 1195\u20131203 (2012).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR173","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1161\/CIRCHEARTFAILURE.109.905968","volume":"3","author":"Y Wang","year":"2010","unstructured":"Wang, Y. et al. Circulating rather than cardiac angiotensin-(1\u20137) stimulates cardioprotection after myocardial infarction. Circ. Heart Fail. 3, 286\u2013293 (2010).","journal-title":"Circ. Heart Fail."},{"key":"BFnrcardio201459_CR174","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.108.184911","volume":"103","author":"C Mercure","year":"2008","unstructured":"Mercure, C. et al. Angiotensin(1\u20137) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ. Res. 103, 1319\u20131326 (2008).","journal-title":"Circ. Res."},{"key":"BFnrcardio201459_CR175","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1177\/1753944709353426","volume":"4","author":"AJ Ferreira","year":"2010","unstructured":"Ferreira, A. J. et al. Attenuation of isoproterenol-induced cardiac fibrosis in transgenic rats harboring an angiotensin-(1\u20137)-producing fusion protein in the heart. Ther. Adv. Cardiovasc. Dis. 4, 83\u201396 (2010).","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"BFnrcardio201459_CR176","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/hr.2009.25","volume":"32","author":"Y Li","year":"2009","unstructured":"Li, Y. et al. Angiotensin (1\u20137) prevent heart dysfunction and left ventricular remodeling caused by renal dysfunction in 5\/6 nephrectomy mice. Hypertens. Res. 32, 369\u2013374 (2009).","journal-title":"Hypertens. Res."},{"key":"BFnrcardio201459_CR177","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0006-8993(00)02482-3","volume":"873","author":"K Feterik","year":"2000","unstructured":"Feterik, K., Smith, L. & Katusic, Z. S. Angiotensin-(1\u20137) causes endothelium-dependent relaxation in canine middle cerebral artery. Brain Res. 873, 75\u201382 (2000).","journal-title":"Brain Res."},{"key":"BFnrcardio201459_CR178","doi-asserted-by":"publisher","first-page":"H1024","DOI":"10.1152\/ajpheart.00328.2010","volume":"299","author":"MJ Durand","year":"2010","unstructured":"Durand, M. J., Raffai, G., Weinberg, B. D. & Lombard, J. H. Angiotensin-(1\u20137) and low-dose angiotensin II infusion reverse salt-induced endothelial dysfunction via different mechanisms in rat middle cerebral arteries. Am. J. Physiol. Heart Circ. Physiol. 299, H1024\u2013H1033 (2010).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"BFnrcardio201459_CR179","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.npep.2013.09.002","volume":"47","author":"J Lu","year":"2013","unstructured":"Lu, J. et al. The expression of angiotensin-converting enzyme 2-angiotensin-(1\u20137)-Mas receptor axis are upregulated after acute cerebral ischemic stroke in rats. Neuropeptides 47, 289\u2013295 (2013).","journal-title":"Neuropeptides"},{"key":"BFnrcardio201459_CR180","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1113\/expphysiol.2011.058578","volume":"96","author":"AP Mecca","year":"2011","unstructured":"Mecca, A. P. et al. Cerebroprotection by angiotensin-(1\u20137) in endothelin-1-induced ischaemic stroke. Exp. Physiol. 96, 1084\u20131096 (2011).","journal-title":"Exp. Physiol."},{"key":"BFnrcardio201459_CR181","doi-asserted-by":"publisher","first-page":"1520","DOI":"10.1111\/j.1476-5381.2012.02105.x","volume":"167","author":"T Jiang","year":"2012","unstructured":"Jiang, T. et al. Suppressing inflammation by inhibiting the NF-kappaB pathway contributes to the neuroprotective effect of angiotensin-(1\u20137) in rats with permanent cerebral ischaemia. Br. J. Pharmacol. 167, 1520\u20131532 (2012).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrcardio201459_CR182","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.neuropharm.2013.03.025","volume":"71","author":"RW Regenhardt","year":"2013","unstructured":"Regenhardt, R. W. et al. Anti-inflammatory effects of angiotensin-(1\u20137) in ischemic stroke. Neuropharmacology 71, 154\u2013163 (2013).","journal-title":"Neuropharmacology"},{"key":"BFnrcardio201459_CR183","doi-asserted-by":"publisher","first-page":"F1374","DOI":"10.1152\/ajprenal.00656.2011","volume":"302","author":"LM Yamaleyeva","year":"2010","unstructured":"Yamaleyeva, L. M. et al. Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes. Am. J. Physiol. Renal Physiol. 302, F1374\u2013F1384 (2010).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrcardio201459_CR184","doi-asserted-by":"publisher","first-page":"e84683","DOI":"10.1371\/journal.pone.0084683","volume":"9","author":"M Riera","year":"2014","unstructured":"Riera, M. et al. Effect of insulin on ACE2 activity and kidney function in the non-obese diabetic mouse. PLoS ONE 9, e84683 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrcardio201459_CR185","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/HJH.0b013e32834f04b6","volume":"30","author":"A Soro-Paavonen","year":"2012","unstructured":"Soro-Paavonen, A. et al. Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J. Hypertens. 30, 375\u2013383 (2012).","journal-title":"J. Hypertens."},{"key":"BFnrcardio201459_CR186","doi-asserted-by":"publisher","first-page":"2540","DOI":"10.2337\/db09-0782","volume":"59","author":"SM Bindom","year":"2010","unstructured":"Bindom, S. M., Hans, C. P., Xia, H., Boulares, A. H. & Lazartigues, E. Angiotensin I-converting enzyme type 2 (ACE2) gene therapy improves glycemic control in diabetic mice. Diabetes 59, 2540\u20132548 (2010).","journal-title":"Diabetes"},{"key":"BFnrcardio201459_CR187","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2337\/db12-0177","volume":"62","author":"M Takeda","year":"2013","unstructured":"Takeda, M. et al. Loss of ACE2 exaggerates high-calorie diet-induced insulin resistance by reduction of GLUT4 in mice. Diabetes 62, 223\u2013233 (2013).","journal-title":"Diabetes"},{"key":"BFnrcardio201459_CR188","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.2337\/db12-0792","volume":"62","author":"Y Marcus","year":"2013","unstructured":"Marcus, Y. et al. Angiotensin 1\u20137 as means to prevent the metabolic syndrome: lessons from the fructose-fed rat model. Diabetes 62, 1121\u20131130 (2013).","journal-title":"Diabetes"},{"key":"BFnrcardio201459_CR189","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.regpep.2012.06.009","volume":"178","author":"SH Santos","year":"2012","unstructured":"Santos, S. H. et al. Increased circulating angiotensin-(1\u20137) protects white adipose tissue against development of a proinflammatory state stimulated by a high-fat diet. Regul. Pept. 178, 64\u201370 (2012).","journal-title":"Regul. Pept."},{"key":"BFnrcardio201459_CR190","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s00109-013-1087-0","volume":"92","author":"SH Santos","year":"2014","unstructured":"Santos, S. H. et al. Oral administration of angiotensin-(1\u20137) ameliorates type 2 diabetes in rats. J. Mol. Med. (Berl.) 92, 255\u2013265 (2014).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"BFnrcardio201459_CR191","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s11906-012-0323-2","volume":"15","author":"PC Underwood","year":"2013","unstructured":"Underwood, P. C. & Adler, G. K. The renin angiotensin aldosterone system and insulin resistance in humans. Curr. Hypertens. Rep. 15, 59\u201370 (2013).","journal-title":"Curr. Hypertens. Rep."},{"key":"BFnrcardio201459_CR192","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1161\/01.RES.0000126501.34994.96","volume":"94","author":"F Andreozzi","year":"2004","unstructured":"Andreozzi, F., Laratta, E., Sciacqua, A., Perticone, F. & Sesti, G. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Circ. Res. 94, 1211\u20131218 (2004).","journal-title":"Circ. Res."},{"key":"BFnrcardio201459_CR193","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/ki.2008.497","volume":"74","author":"HN Reich","year":"2008","unstructured":"Reich, H. N., Oudit, G. Y., Penninger, J. M., Scholey, J. W. & Herzenberg, A. M. Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease. Kidney Int. 74, 1610\u20131616 (2008).","journal-title":"Kidney Int."},{"key":"BFnrcardio201459_CR194","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1681\/ASN.2006050423","volume":"17","author":"M Ye","year":"2006","unstructured":"Ye, M. et al. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. J. Am. Soc. Nephrol. 17, 3067\u20133075 (2006).","journal-title":"J. Am. Soc. Nephrol."},{"key":"BFnrcardio201459_CR195","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1053\/j.ajkd.2007.11.022","volume":"51","author":"S Mizuiri","year":"2008","unstructured":"Mizuiri, S. et al. Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. Am. J. Kidney Dis. 51, 613\u2013623 (2008).","journal-title":"Am. J. Kidney Dis."},{"key":"BFnrcardio201459_CR196","doi-asserted-by":"publisher","first-page":"438","DOI":"10.2353\/ajpath.2007.060977","volume":"171","author":"DW Wong","year":"2007","unstructured":"Wong, D. W. et al. Loss of angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. Am. J. Pathol. 171, 438\u2013451 (2007).","journal-title":"Am. J. Pathol."},{"key":"BFnrcardio201459_CR197","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/hr.2009.231","volume":"33","author":"A Shiota","year":"2010","unstructured":"Shiota, A. et al. Loss of ACE2 accelerates time-dependent glomerular and tubulointerstitial damage in streptozotocin-induced diabetic mice. Hypertens. Res. 33, 298\u2013307 (2010).","journal-title":"Hypertens. Res."},{"key":"BFnrcardio201459_CR198","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2337\/db09-1218","volume":"59","author":"GY Oudit","year":"2010","unstructured":"Oudit, G. Y. et al. Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 59, 529\u2013538 (2010).","journal-title":"Diabetes"},{"key":"BFnrcardio201459_CR199","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2119\/molmed.2010.00111","volume":"17","author":"CX Liu","year":"2011","unstructured":"Liu, C. X. et al. Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition. Mol. Med. 17, 59\u201369 (2011).","journal-title":"Mol. Med."},{"key":"BFnrcardio201459_CR200","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/ki.2012.83","volume":"82","author":"R Nadarajah","year":"2012","unstructured":"Nadarajah, R. et al. Podocyte-specific overexpression of human angiotensin-converting enzyme 2 attenuates diabetic nephropathy in mice. Kidney Int. 82, 292\u2013303 (2012).","journal-title":"Kidney Int."},{"key":"BFnrcardio201459_CR201","doi-asserted-by":"publisher","first-page":"F1606","DOI":"10.1152\/ajprenal.00063.2012","volume":"302","author":"JF Giani","year":"2012","unstructured":"Giani, J. F. et al. Angiotensin-(1\u20137) attenuates diabetic nephropathy in Zucker diabetic fatty rats. Am. J. Physiol. Renal Physiol. 302, F1606\u2013F1615 (2012).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"BFnrcardio201459_CR202","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1016\/j.peptides.2005.01.009","volume":"26","author":"F Gembardt","year":"2005","unstructured":"Gembardt, F. et al. Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides 26, 1270\u20131277 (2005).","journal-title":"Peptides"},{"key":"BFnrcardio201459_CR203","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature11228","volume":"487","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto, T. et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487, 477\u2013481 (2012).","journal-title":"Nature"},{"key":"BFnrcardio201459_CR204","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature09922","volume":"472","author":"Z Wang","year":"2011","unstructured":"Wang, Z. et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472, 57\u201363 (2011).","journal-title":"Nature"},{"key":"BFnrcardio201459_CR205","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s40262-013-0072-7","volume":"52","author":"M Haschke","year":"2013","unstructured":"Haschke, M. et al. Pharmacokinetics and pharmacodynamics of recombinant human angiotensin-converting enzyme 2 in healthy human subjects. Clin. Pharmacokinet 52, 783\u2013792 (2013).","journal-title":"Clin. Pharmacokinet"},{"key":"BFnrcardio201459_CR206","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00280-005-0078-4","volume":"57","author":"KE Rodgers","year":"2006","unstructured":"Rodgers, K. E., Oliver, J. & diZerega, G. S. Phase I\/II dose escalation study of angiotensin 1\u20137 [A(1\u20137)] administered before and after chemotherapy in patients with newly diagnosed breast cancer. Cancer Chemother. Pharmacol. 57, 559\u2013568 (2006).","journal-title":"Cancer Chemother. Pharmacol."},{"key":"BFnrcardio201459_CR207","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1161\/01.HYP.34.3.457","volume":"34","author":"AP Davie","year":"1999","unstructured":"Davie, A. P. & McMurray, J. J. Effect of angiotensin-(1\u20137) and bradykinin in patients with heart failure treated with an ACE inhibitor. Hypertension 34, 457\u2013460 (1999).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR208","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1124\/jpet.108.146431","volume":"328","author":"LD Kluskens","year":"2009","unstructured":"Kluskens, L. D. et al. Angiotensin-(1\u20137) with thioether bridge: an angiotensin-converting enzyme-resistant, potent angiotensin-(1\u20137) analog. J. Pharmacol. Exp. Ther. 328, 849\u2013854 (2009).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"BFnrcardio201459_CR209","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/j.peptides.2010.02.015","volume":"31","author":"L de Vries","year":"2010","unstructured":"de Vries, L. et al. Oral and pulmonary delivery of thioether-bridged angiotensin-(1\u20137). Peptides 31, 893\u2013898 (2010).","journal-title":"Peptides"},{"key":"BFnrcardio201459_CR210","doi-asserted-by":"publisher","first-page":"536426","DOI":"10.1155\/2012\/536426","volume":"2012","author":"M Durik","year":"2012","unstructured":"Durik, M. et al. The effect of the thioether-bridged, stabilized angiotensin-(1\u20137) analogue cyclic ang-(1\u20137) on cardiac remodeling and endothelial function in rats with myocardial infarction. Int. J. Hypertens. 2012, 536426 (2012).","journal-title":"Int. J. Hypertens."},{"key":"BFnrcardio201459_CR211","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1161\/HYPERTENSIONAHA.110.167346","volume":"57","author":"FD Marques","year":"2011","unstructured":"Marques, F. D. et al. An oral formulation of angiotensin-(1\u20137) produces cardioprotective effects in infarcted and isoproterenol-treated rats. Hypertension 57, 477\u2013483 (2011).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR212","doi-asserted-by":"publisher","first-page":"795452","DOI":"10.1155\/2012\/795452","volume":"2012","author":"FD Marques","year":"2012","unstructured":"Marques, F. D. et al. Beneficial effects of long-term administration of an oral formulation of angiotensin-(1\u20137) in infarcted rats. Int. J. Hypertens. 2012, 795452 (2012).","journal-title":"Int. J. Hypertens."},{"key":"BFnrcardio201459_CR213","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1161\/HYPERTENSIONAHA.111.00919","volume":"62","author":"JD Feltenberger","year":"2013","unstructured":"Feltenberger, J. D. et al. Oral formulation of angiotensin-(1\u20137) improves lipid metabolism and prevents high-fat diet-induced hepatic steatosis and inflammation in mice. Hypertension 62, 324\u2013330 (2013).","journal-title":"Hypertension"},{"key":"BFnrcardio201459_CR214","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1042\/CS20120461","volume":"124","author":"DG Passos-Silva","year":"2013","unstructured":"Passos-Silva, D. G., Verano-Braga, T. & Santos, R. A. Angiotensin-(1\u20137): beyond the cardio-renal actions. Clin. Sci. (Lond.) 124, 443\u2013456 (2013).","journal-title":"Clin. Sci. (Lond.)"},{"key":"BFnrcardio201459_CR215","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/hr.2010.235","volume":"34","author":"LA Rabelo","year":"2011","unstructured":"Rabelo, L. A., Alenina, N. & Bader, M. ACE2-angiotensin-(1\u20137)-Mas axis and oxidative stress in cardiovascular disease. Hypertens. Res. 34, 154\u2013160 (2011).","journal-title":"Hypertens. Res."},{"key":"BFnrcardio201459_CR216","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bph.12159","volume":"169","author":"AC Simoes e Silva","year":"2013","unstructured":"Simoes e Silva, A. C., Silveira, K. D., Ferreira, A. J. & Teixeira, M. M. ACE2, angiotensin-(1\u20137) and Mas receptor axis in inflammation and fibrosis. Br. J. Pharmacol. 169, 477\u2013492 (2013).","journal-title":"Br. J. Pharmacol."},{"key":"BFnrcardio201459_CR217","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s11906-010-0105-7","volume":"12","author":"H Xia","year":"2010","unstructured":"Xia, H. & Lazartigues, E. Angiotensin-converting enzyme 2: central regulator for cardiovascular function. Curr. Hypertens. Rep. 12, 170\u2013175 (2010).","journal-title":"Curr. Hypertens. Rep."},{"key":"BFnrcardio201459_CR218","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1517\/13543776.2012.682572","volume":"22","author":"AJ Ferreira","year":"2012","unstructured":"Ferreira, A. J., Bader, M. & Santos, R. A. Therapeutic targeting of the angiotensin-converting enzyme 2\/angiotensin-(1\u20137)\/Mas cascade in the renin-angiotensin system: a patent review. Expert Opin. Ther. Pat. 22, 567\u2013574 (2012).","journal-title":"Expert Opin. Ther. Pat."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2014.59.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2014.59","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2014.59.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T12:13:28Z","timestamp":1746188008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2014.59"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,29]]},"references-count":218,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["BFnrcardio201459"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2014.59","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,29]]},"assertion":[{"value":"29 April 2014","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}